Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[68Ga]P137 PET Imaging in Prostate Cancer
NCT04560725Active, not recruiting
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Oct 2020
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Peking University Cancer Hospital & Institute. Primary endpoint: Standardized Uptake Value at 2 years. Started Oct 2020; status: active, not recruiting.
Beyond the preview
Go deeper on NCT04560725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04560725.